Recurrence of Pancreatic Neuroendocrine Tumors and Survival Predicted by Ki67

BACKGROUND: Despite evidence of different malignant potentials, postoperative follow-up assessment is similar for G1 and G2 pancreatic neuroendocrine tumors (panNETs) and adjuvant treatment currently is not indicated. This study investigated the role of Ki67 with regard to recurrence and survival af...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Ann Surg Oncol
Autors principals: Genç, C. G., Falconi, M., Partelli, S., Muffatti, F., van Eeden, S., Doglioni, C., Klümpen, H. J., van Eijck, C. H. J., Nieveen van Dijkum, E. J. M.
Format: Artigo
Idioma:Inglês
Publicat: Springer International Publishing 2018
Matèries:
Pancreatic Tumors
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6028862/
https://ncbi.nlm.nih.gov/pubmed/29789972
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-018-6518-2
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars